Since joining Indiana University, his research is focused on the discovery and implementation of genomic predictors of drug response. More specifically, his studies are focused on genetic variants in the ADME genes.
They also include studies to identify miRNAs that contribute to the drug-induced and developmental changes in hepatic drug metabolism.
Research: Identification of mechanisms in breast cancer cells and patients that alter their responsiveness to endocrine therapies. Dr. Skaar’s research is focused on the discovery and implementation of genomic predictors of drug response. The discovery studies include identifying genetic variants that are associated with clinical drug efficacy and toxicity
Subject Area: Medicine.
Subject area: Precision Medicine
